Adc Therapeutics SA (ADCT) — DEFA14A Filings
All DEFA14A filings from Adc Therapeutics SA. Browse 3 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (3)
- DEFA14A Filing — Apr 20, 2026
-
ADC Therapeutics SA Proxy Materials Filed
— Apr 21, 2025 Risk: low
ADC Therapeutics SA filed a Definitive Additional Materials proxy statement on April 21, 2025. The filing relates to the company's proxy materials and provides -
ADC Therapeutics SA Files Proxy Statement
— Apr 26, 2024 Risk: low
ADC Therapeutics SA filed a Definitive Additional Materials proxy statement on April 26, 2024. The filing, identified by accession number 0000950103-24-005844,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX